135 results
Page 4 of 7
8-K
EX-99.2
e6zft jl5f
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.56
kys5aa3c9shxcavk
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.59
cak69w nr
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.53
xofuco
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.58
udxa6n
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.57
t39jv 6seqf0c
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.54
8b6fx odee8fswjz12
23 Jun 20
Draft registration statement
12:00am
DRS
ca1pmj prw
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.55
7hr9 9t4bib5shqz
23 Jun 20
Draft registration statement
12:00am
DEFA14A
ls7165vf7x
8 May 20
Additional proxy soliciting materials
4:10pm
D
8i67t0j
8 May 20
$32.44M in equity, sold $32.44M, 1 investor
4:04pm
D
uoh6r72p57bk42pu7j
8 May 20
$250M in equity, sold $250M, 1 investor
4:01pm
DEFA14A
yfkiddmedxgoeqgu
6 Apr 20
Additional proxy soliciting materials
4:53pm
DEF 14A
awq683
6 Apr 20
Definitive proxy
4:52pm
10-K
2zqgomn 5v8cmifw6b
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
gaw0mk2c7e3nlyci0
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
10-Q
vrnyinkx
19 Nov 19
Quarterly report
4:06pm
8-K
EX-3.2
0tv0p7jcqtun1kig109
16 Oct 19
Departure of Directors or Certain Officers
4:01pm
424B4
hm3xg
11 Oct 19
Prospectus supplement with pricing info
5:31pm